Bragar Eagel Investigates Organon After 28% Crash, Dividend Cut.
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has opened an investigation into Organon & Co. (NYSE: OGN) after the company’s stock dropped sharply following disappointing quarterly results and a drastic dividend reduction.
The firm is examining potential violations of federal securities laws or other corporate misconduct.
The investigation follows Organon’s May 1, 2025 earnings report, which revealed a 7% year-over-year revenue decline to $1.51 billion, driven by a 17% drop in Biosimilars and an 11% decline in Established Brands after losing exclusivity for Atozet.
Organon announced a reduction in its quarterly dividend from $0.28 to $0.02 per share, a cut of over 92%. The announcement triggered a significant selloff, with the company’s stock price declining more than 28% in a single trading session.
Bragar Eagel & Squire, P.C. is currently investigating potential claims on behalf of investors who suffered losses. The firm is offering no-cost consultations to evaluate whether shareholders may be eligible to participate in a class action or pursue other legal recourse.
What Investors Should Know
If you invested in Organon and suffered financial losses, or if you have information related to the company’s recent disclosures, you may be entitled to compensation. There is no cost or obligation to participate.
📧 Contact Bragar Eagel & Squire, P.C.
Email: investigations@bespc.com
Phone: (212) 355-4648
Or submit a form here
This investigation is ongoing. Investors are encouraged to act promptly.
Bragar Eagel & Squire, P.C. is a nationally recognized law firm focused on securities litigation, corporate governance, and complex commercial disputes. Based in New York, the firm represents individual and institutional investors in high-stakes cases nationwide. With a strong track record of recoveries totaling over a billion dollars, Bragar Eagel is known for its aggressive advocacy, strategic litigation, and commitment to investor rights.
More Articles
